Alopecia areata |
GLYCOGEN STORAGE DISEASE Ia; GSD1A |
Intracranial aneurysm |
GLYCOGEN STORAGE DISEASE II; GSD2 |
Rheumatoid arthritis |
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2 |
Chronic bronchitis and chronic obstructive pulmonary disease |
HERMANSKY-PUDLAK SYNDROME 3; HPS3 |
Breast cancer GWAS |
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME |
Breast Cancer: pathogenic SNP carrier |
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED |
Ovarian cancer in BRCA1 mutation carriers |
JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1 |
Prostate cancer |
JOUBERT SYNDROME 14; JBTS14 |
Prostate cancer aggressiveness |
JOUBERT SYNDROME 16; JBTS16 |
Prostate cancer (early onset) |
JOUBERT SYNDROME 3; JBTS3 |
Bladder cancer |
JOUBERT SYNDROME 5; JBTS5 |
Upper aerodigestive tract cancers |
JOUBERT SYNDROME 7; JBTS7 |
Basal cell carcinoma |
JOUBERT SYNDROME 8; JBTS8 |
Motion sickness |
JOUBERT SYNDROME 9; JBTS9 |
Primary biliary cirrhosis |
KABUKI SYNDROME 1; KABUK1 |
Age-related macular degeneration |
LEIGH SYNDROME; LS |
Conduct disorder |
LEOPARD SYNDROME 1; LPRD1 |
Type 1 diabetes |
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM |
Type 1 diabetes nephropathy |
LISSENCEPHALY 1; LIS1 |
Type 2 diabetes |
LOEYS-DIETZ SYNDROME 2; LDS2 |
Endometriosis |
LONG QT SYNDROME 1; LQT1 |
Celiac disease |
LYNCH SYNDROME I |
Alzheimer’s disease (late onset) |
MAPLE SYRUP URINE DISEASE; MSUD |
Coronary heart disease |
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2 |
Parkinson’s disease |
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3 |
Multiple sclerosis |
MECKEL SYNDROME, TYPE 3; MKS3 |
Systemic sclerosis |
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH |
Schizophrenia |
METACHROMATIC LEUKODYSTROPHY; MLD |
Glioma |
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE |
Hypothyroidism |
METHYLMALONIC ACIDURIA, cblA TYPE |
Myocardial infarction (early onset) |
METHYLMALONIC ACIDURIA, cblB TYPE |
Chronic lymphocytic leukemia |
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1; MC3DN1 |
Hodgkin’s lymphoma |
MUCOPOLYSACCHARIDOSIS TYPE VI; MPS6 |
Diffuse large B cell lymphoma |
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7 |
Follicular lymphoma |
MUCOPOLYSACCHARIDOSIS, TYPE IIIA; MPS3A |
Myasthenia gravis |
MUCOPOLYSACCHARIDOSIS, TYPE IIIB; MPS3B |
Multiple myeloma |
MUCOPOLYSACCHARIDOSIS, TYPE IVA; MPS4A |
Neuroblastoma |
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1 |
Osteosarcoma |
MYOPATHY, MYOFIBRILLAR, 1; MFM1 |
Psoriasis |
MYOPATHY, CENTRONUCLEAR, 1; CNM1 |
Allergic sensitization |
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX |
Testicular germ cell tumor |
NEMALINE MYOPATHY 2; NEM2 |
Wilms tumor |
CYSTINOSIS, NEPHROPATHIC; CTNS |
Vitiligo |
NIEMANN-PICK DISEASE, TYPE C1; NPC1 |
17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY |
NIEMANN-PICK DISEASE, TYPE A |
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D |
NIEMANN-PICK DISEASE, TYPE B |
AARSKOG-SCOTT SYNDROME; AAS |
NOONAN SYNDROME 1; NS1 |
ACHROMATOPSIA 2; ACHM2 |
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA; NSLL |
LEUKEMIA, ACUTE MYELOID; AML |
NOONAN SYNDROME 4; NS4 |
ADRENOLEUKODYSTROPHY; ALD |
Obesity due to melanocortin 4 receptor deficiency |
HYPOPHOSPHATASIA, ADULT |
ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B |
ALLAN-HERNDON-DUDLEY SYNDROME; AHDS |
OSTEOGENESIS IMPERFECTA, TYPE III; OI3 |
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD |
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM |
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED |
PITT-HOPKINS SYNDROME; PTHS |
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY |
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL; BFPP |
ANGELMAN SYNDROME; AS |
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5 |
ANTITHROMBIN III DEFICIENCY; AT3D |
RETINITIS PIGMENTOSA; RP |
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10; ARVD10 |
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1 |
AURICULOCONDYLAR SYNDROME 1; ARCND1 |
SOTOS SYNDROME 1; SOTOS1 |
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT; ADHR |
SUPRAVALVULAR AORTIC STENOSIS; SVAS |
BARDET-BIEDL SYNDROME 1; BBS1 |
TAY-SACHS DISEASE; TSD |
MUSCULAR DYSTROPHY, BECKER TYPE; BMD |
TUBEROUS SCLEROSIS 1; TSC1 |
BETA-THALASSEMIA |
TUBEROUS SCLEROSIS 2; TSC2 |
BLOOM SYNDROME; BLM |
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A |
BRUGADA SYNDROME 1; BRGDA1 |
TYROSINEMIA, TYPE I; TYRSN1 |
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1 |
USHER SYNDROME, TYPE I; USH1 |
CARDIOMYOPATHY, DILATED, 1S; CMD1S |
USHER SYNDROME, TYPE ID; USH1D |
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1 |
USHER SYNDROME, TYPE IF; USH1F |
CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1 |
USHER SYNDROME, TYPE IIA; USH2A |
CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7 |
USHER SYNDROME, TYPE IIC; USH2C |
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C |
USHER SYNDROME, TYPE IID; USH2D |
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1 |
USHER SYNDROME, TYPE IIIA; USH3A |
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX |
ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD |
ADRENAL HYPOPLASIA, CONGENITAL; AHC |
VON HIPPEL-LINDAU SYNDROME; VHL |
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C |
WEAVER SYNDROME; WVS |
CORNELIA DE LANGE SYNDROME 1; CDLS1 |
Wilson Disease |
COSTELLO SYNDROME; CSTLO |
AGAMMAGLOBULINEMIA, X-LINKED; XLA |
CYSTIC FIBROSIS; CF |
|
DANON DISEASE |
|
DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1A |
|
DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31 |
|
DEAFNESS, AUTOSOMAL RECESSIVE 7; DFNB7 |
|
DEAFNESS, AUTOSOMAL RECESSIVE 9; DFNB9 |
|
MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA |
|
CARDIOMYOPATHY, DILATED, 1A; CMD1A |
|
DUBIN-JOHNSON SYNDROME; DJS |
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2 |
MYOCLONIC EPILEPSY OF LAFORA |
|
ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2 |
|
FABRY DISEASE |
|
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1 |
|
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2 |
FAMILIAL MEDITERRANEAN FEVER; FMF |
|
THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC |
FANCONI ANEMIA, COMPLEMENTATION GROUP O; FANCO |
NEPHROTIC SYNDROME, TYPE 1; NPHS1 |
|
GAUCHER DISEASE, TYPE I |
|
GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1 |
|
GLUTARIC ACIDEMIA I; GA1 |
|
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD |